"10.1371_journal.pone.0037504","plos one","2012-05-25T00:00:00Z","Winfried Häuser; Eva Jung; Brigitte Erbslöh-Möller; Mechthild Gesmann; Hedi Kühn-Becker; Franz Petermann; Jost Langhorst; Thomas Weiss; Andreas Winkelmann; Frederick Wolfe","Department Internal Medicine I, Klinikum Saarbrücken, Saarbrücken, Germany; Department of Psychosomatic Medicine and Psychotherapy, Technische Universität München, München, Germany; Rheumatology Medical Practice, Neunkirchen, Germany; Psychosomatic Medicine and Pain Therapy Medical Practice, Herford, Germany; Psychosomatic Medicine and Pain Therapy Medical Practice, Zweibrücken, Germany; Centre of Clinical Psychology and Rehabilitation, Universität Bremen, Bremen, Germany; Department Internal Medicine V (Intergrative Medicine), Kliniken Essen-Mitte, Essen, Germany; Outpatient Clinic Mannheim, Mannheim, Germany; Department of Physical Medicine and Rehabilitation, Klinikum der Universität München, München, Germany; National Data Bank for Rheumatic Diseases, Wichita, Kansas, United States of America; University of Kansas School of Medicine, Wichita, Kansas, United States of America","Conceived and designed the experiments: WH FW. Analyzed the data: WH EJ FW. Contributed reagents/materials/analysis tools: WH BEM MG HKB FP JL TW AW. Wrote the paper: WH EJ FW.","The authors have read the journal's policy and have the following conflicts: Dr. Häuser received honoraria for education lectures from Eli-Lilly, Pfizer and Janssen-Cilag and a congress travel grant by Eli-Lilly. Dr Weiss and Dr. Winkelmann were investigators in a study of pregabalin in FMS, sponsored by Pfizer. The other authors have no conflicts of interest to declare. This does not alter the authors' adherence to all PLOS ONE policies on sharing data and materials.","2012","05","Winfried Häuser","WH",10,TRUE,2,NA,3,3,TRUE,TRUE,FALSE,0,NA,FALSE
